Background The association between obesity and dementia risk remains debatable and no studies have assessed this association among diabetic patients. The aim of our study was to investigate the association between body mass index (BMI) and dementia risk among middle and low income diabetic patients. Methodology/Principal Findings The sample included 44,660 diabetic patients (19,618 white and 25,042 African American) 30 to 96 years of age without a history of dementia in the Louisiana State University Hospital-Based Longitudinal Study. During a mean follow-up period of 3.9 years, 388 subjects developed incident dementia. The age- and sex-adjusted hazards ratios (HRs) for incident dementia at different levels of BMI (≤25, 25–26.9, 27–29.9, 30–34.9, and ≥35 kg/m2) were 1.00, 0.53 (95% CI 0.34–0.83), 0.29 (0.18–0.45), 0.37 (0.25–0.56), and 0.31 (0.21–0.48) (Ptrend<0.001) in white diabetic patients, and 1.00, 1.00 (95% CI 0.62–1.63), 0.62 (0.39–0.98), 0.56 (0.36–0.86), and 0.65 (0.43–1.01) (Ptrend = 0.029) in African American diabetic patients. Further adjustment for other confounding factors affected the results only slightly. There was a significant interaction between race and BMI on dementia risk (χ2 = 5.52, 1df, p<0.025), such that the association was stronger in white patients. In stratified analyses, the multivariate-adjusted inverse association between BMI and risk of dementia was present in subjects aged 55–64 years, 65–74 years, and ≥75 years, in men and women, in non-smokers and smokers, and in subjects with different types of health insurance. Conclusions/Significance Higher baseline BMI was associated with a lower risk of dementia among diabetic patients, and this association was stronger among white than among African American diabetic patients.
References
[1]
Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303: 235–241.
[2]
Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, et al. (2009) Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care 32: 287–294.
[3]
Centers for Disease Control and Prevention (2007) National diabetes fact sheet: United States 2007. Atlanta: Centers for Disease Control and Prevention; U.S. Department of Health and Human Services.
[4]
Kanaya AM, Adler N, Moffet HH, Liu J, Schillinger D, et al. (2011) Heterogeneity of diabetes outcomes among asians and pacific islanders in the US: the diabetes study of northern california (DISTANCE). Diabetes Care 34: 930–937.
[5]
Hu G, Barengo NC, Tuomilehto J, Lakka TA, Nissinen A, et al. (2004) Relationship of Physical Activity and Body Mass Index to the Risk of Hypertension: A Prospective Study in Finland. Hypertension 43: 25–30.
[6]
Hu G, Lindstrom J, Valle TT, Eriksson JG, Jousilahti P, et al. (2004) Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch Intern Med 164: 892–896.
[7]
Klein S, Allison DB, Heymsfield SB, Kelley DE, Leibel RL, et al. (2007) Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr 85: 1197–1202.
[8]
Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Peltonen M, et al. (2005) The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women. Int J Obes (Lond) 29: 894–902.
[9]
Hu G, Tuomilehto J, Silventoinen K, Barengo N, Jousilahti P (2004) Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. Eur Heart J 25: 2212–2219.
[10]
Hu G, Jousilahti P, Antikainen R, Katzmarzyk PT, Tuomilehto J (2010) Joint Effects of Physical Activity, Body Mass Index, Waist Circumference, and Waist-to-Hip Ratio on the Risk of Heart Failure. Circulation 121: 237–244.
[11]
Hu G, Tuomilehto J, Silventoinen K, Sarti C, Mannisto S, et al. (2007) Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med 167: 1420–1427.
[12]
Hu G, Jousilahti P, Nissinen A, Antikainen R, Kivipelto M, et al. (2006) Body mass index and the risk of Parkinson disease. Neurology 67: 1955–1959.
[13]
Hughes E, Kilmer G, Li Y, Valluru B, Brown J, et al. (2010) Surveillance for certain health behaviors among states and selected local areas – United States, 2008. MMWR Surveill Summ 59: 1–221.
[14]
Anstey KJ, Cherbuin N, Budge M, Young J (2011) Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev 12: e426–437.
[15]
Plassman BL, Williams JW Jr, Burke JR, Holsinger T, Benjamin S (2010) Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med 153: 182–193.
[16]
Gustafson DR, Backman K, Joas E, Waern M, Ostling S, et al. (2012) 37 years of body mass index and dementia: observations from the prospective population study of women in Gothenburg, Sweden. J Alzheimers Dis 28: 163–171.
[17]
Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, et al. (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62: 1556–1560.
[18]
Rosengren A, Skoog I, Gustafson D, Wilhelmsen L (2005) Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med 165: 321–326.
[19]
Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP Jr, Yaffe K (2005) Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 330: 1360.
[20]
Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, et al. (2009) Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol 66: 336–342.
[21]
Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, et al. (2008) Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc 56: 111–116.
[22]
Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R (2007) Measures of adiposity and dementia risk in elderly persons. Arch Neurol 64: 392–398.
[23]
Hughes TF, Borenstein AR, Schofield E, Wu Y, Larson EB (2009) Association between late-life body mass index and dementia: The Kame Project. Neurology 72: 1741–1746.
[24]
Power BD, Alfonso H, Flicker L, Hankey GJ, Yeap BB, et al. (2011) Body adiposity in later life and the incidence of dementia: the health in men study. PLoS One 6: e17902.
[25]
Alzheimer's Association (2012) 2012 Alzheimer's disease facts and figures. Alzheimers Dement 8: 131–168.
[26]
Li W, Wang Y, Chen L, Horswell R, Xiao K, et al. (2011) Increasing prevalence of diabetes in middle or low income residents in Louisiana from 2000 to 2009. Diabetes Res Clin Pract 94: 262–268.
[27]
Wang Y, Chen L, Xiao K, Horswell R, Besse J, et al. (2012) Increasing incidence of gestational diabetes mellitus in louisiana, 1997–2009. J Womens Health (Larchmt) 21: 319–325.
[28]
Wang Y, Chen L, Horswell R, Xiao K, Besse J, et al. (2012) Racial Disparities in the Association Between Gestational Diabetes Mellitus and Risk of Type 2 Diabetes. J Womens Health (Larchmt) 21: 628–633.
[29]
Hemkens LG, Grouven U, Bender R, Gunster C, Gutschmidt S, et al. (2009) Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 52: 1732–1744.
[30]
American Diabetes Association (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183–1197.
[31]
American Diabetes Association (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl 1S5–20.
[32]
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association.
[33]
McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939–944.
[34]
Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, et al. (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250–260.
[35]
Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc B 34: 187–220.
[36]
Stewart R, Masaki K, Xue QL, Peila R, Petrovitch H, et al. (2005) A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 62: 55–60.
[37]
Qiu C, De Ronchi D, Fratiglioni L (2007) The epidemiology of the dementias: an update. Curr Opin Psychiatry 20: 380–385.
[38]
Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I (2003) An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163: 1524–1528.
[39]
Xu W, Qiu C, Gatz M, Pedersen NL, Johansson B, et al. (2009) Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 58: 71–77.
[40]
Katzmarzyk PT, Bray GA, Greenway FL, Johnson WD, Newton RL Jr, et al. (2010) Racial differences in abdominal depot-specific adiposity in white and African American adults. Am J Clin Nutr 91: 7–15.
[41]
Hu G, Bouchard C, Bray GA, Greenway FL, Johnson WD, et al. (2011) Trunk versus extremity adiposity and cardiometabolic risk factors in white and African American adults. Diabetes Care 34: 1415–1418.
[42]
Kamogawa K, Kohara K, Tabara Y, Uetani E, Nagai T, et al. (2010) Abdominal fat, adipose-derived hormones and mild cognitive impairment: the J-SHIPP study. Dement Geriatr Cogn Disord 30: 432–439.
[43]
Yamamoto H, Kato Y (1993) Relationship between plasma insulin-like growth factor I (IGF-I) levels and body mass index (BMI) in adults. Endocr J 40: 41–45.
Okereke O, Kang JH, Ma J, Hankinson SE, Pollak MN, et al. (2007) Plasma IGF-I levels and cognitive performance in older women. Neurobiol Aging 28: 135–142.
[46]
Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, et al. (2009) Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 302: 2565–2572.
[47]
Phung TK, Andersen BB, Hogh P, Kessing LV, Mortensen PB, et al. (2007) Validity of dementia diagnoses in the Danish hospital registers. Dement Geriatr Cogn Disord 24: 220–228.
[48]
Alonso A, Mosley TH Jr, Gottesman RF, Catellier D, Sharrett AR, et al. (2009) Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study. J Neurol Neurosurg Psychiatry 80: 1194–1201.
